Dr. Roger McIntyre is the chairman and chief executive officer of Braxia Scientific. Dr. McIntyre is the world’s top-ranked depression researcher and has almost 25 years of providing care and conducting research, along with drug discovery and development, for persons with depression and related disorders.
He is a professor of psychiatry and pharmacology at the University of Toronto and Head of the Mood Disorders, Psychopharmacology Unit at the University Health Network in Toronto. Dr. McIntyre serves as the Executive Director of the Brain and Cognition Discovery Foundation in Toronto and is the Director and Co-Chair of the Scientific Advisory Board of the Depression and Bipolar Support Alliance. He was named by Clarivate Analytics in 2014, 2015, 2016, 2017, 2018, 2019, 2020 and 2021 as one of “The World’s Most Influential Scientific Minds”.
Dr. McIntyre has authored/co-authored more than 785 publications, and has edited and/or co-edited several textbooks on mood disorders. He is involved in multiple research endeavors which primarily aim to characterize the phenomenology, neurobiology, and novel therapeutics of mood disorders.
Dr. McIntyre has been especially interested in identifying innovative, rapid acting psychotropic treatments for mood disorders.
Dr. McIntyre’s research has also extended into public health and implementation research at the population-based level.